March 16, 2026

Sunscreen Costs Vary Up to 36-Fold

Economic analysis finds large differences in the annual cost of recommended sunscreen use depending on product price and clothing-based sun protection strategies

Conexiant

March 02, 2026

Skin Fluorescent Imaging Shows High Sensitivity, Specificity for Discriminating Melanoma Lesions

Skin fluorescent imaging demonstrated high sensitivity and specificity for the discrimination of low- and high-risk lesions, showing an alternative, noninvasive approach to melanoma biopsies, accordin...

The ASCO Post

February 24, 2026

Adjuvant Coformulated Vibostolimab Plus Pembrolizumab in High-Risk Stage IIB to IV Melanoma

In an interim analysis of a phase III trial (KEYVIBE-010) reported in The Lancet Oncology, Dummer et al found that adjuvant therapy with a coformulation of the anti-TIGIT antibody vibostolimab with pe...

The ASCO Post

February 23, 2026

Acral Melanoma: Ancestry and Genetics Impact Outcomes

A genetic study of Mexican patients with acral melanoma revealed that the cancer subtype encompasses three groups that may each have distinct gene expressions associated with different survival outcom...

The ASCO Post

February 18, 2026

Patterns of Spread in Ocular Melanoma

Study examines lymphatic and distant metastasis risk

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

May 27, 2021

Study Finds Adjuvant Immunotherapy of Benefit to Patients With Stage IIB/C Melanoma

A significant survival advantage accrued to patients with stage IIB and IIC cutaneous melanoma who received adjuvant immunotherapy, a large retrospective cohort study reported at the Society of Surgic...

The ASCO Post

April 17, 2023

Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma

Monotherapy with pembrolizumab led to clinical responses in 89% of patients with unresectable metastatic desmoplastic melanoma, according to results from the phase II S1512 clinical trial presented by...

The ASCO Post

April 30, 2024

Study Explores Impact of Cannabis Extract on Melanoma Cells

The cannabis extract cannabinoid PHEC-66 may effectively treat melanoma.

Conexiant

April 30, 2024

Model for Predicting Survival Following SLNB in Melanoma

Researchers have developed a model for the prediction of recurrence-free and melanoma-specific survival after sentinel lymph node biopsy (SLNB) in patients with melanoma.

Conexiant